Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Arrowhead Pharmaceuticals (ARWR) Return on Assets (2016 - 2025)

Historic Return on Assets for Arrowhead Pharmaceuticals (ARWR) over the last 15 years, with Q4 2025 value amounting to 0.16%.

  • Arrowhead Pharmaceuticals' Return on Assets rose 7600.0% to 0.16% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.16%, marking a year-over-year increase of 7600.0%. This contributed to the annual value of 0.02% for FY2025, which is 6600.0% up from last year.
  • Arrowhead Pharmaceuticals' Return on Assets amounted to 0.16% in Q4 2025, which was up 7600.0% from 0.02% recorded in Q3 2025.
  • Arrowhead Pharmaceuticals' 5-year Return on Assets high stood at 0.16% for Q4 2025, and its period low was 0.6% during Q1 2024.
  • Its 5-year average for Return on Assets is 0.26%, with a median of 0.2% in 2022.
  • Its Return on Assets has fluctuated over the past 5 years, first plummeted by -4300bps in 2024, then surged by 7600bps in 2025.
  • Quarter analysis of 5 years shows Arrowhead Pharmaceuticals' Return on Assets stood at 0.27% in 2021, then grew by 28bps to 0.2% in 2022, then plummeted by -122bps to 0.44% in 2023, then crashed by -39bps to 0.6% in 2024, then skyrocketed by 126bps to 0.16% in 2025.
  • Its Return on Assets was 0.16% in Q4 2025, compared to 0.02% in Q3 2025 and 0.11% in Q2 2025.